{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:14Z","timestamp":1792716914736,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Artificial daylight photodynamic therapy (ADL-PDT) is an alternative, all-year applicable, nearly painless treatment approach for actinic keratosis (AK) with comparable effectiveness to daylight or conventional PDT. At the time this study was initiated, methyl aminolaevulinate (MAL) was the only photosensitizer approved for ADL-PDT in Germany.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To gain comprehensive insights into the practicability of MAL-ADL-PDT in patients with AK using different artificial daylight sources under real-world conditions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective, noninterventional, multicentre study (ArtLight, NCT05725213) enrolled patients with Olsen grade 1 or 2 AK on the face and scalp in Germany. Patients were treated with MAL-ADL-PDT (160\u2005mg g\u20131 MAL cream). The primary outcome measure was the practicability of MAL-ADL-PDT assessed as rate of resolved AK lesions in the focus area (10 \u00d7 10-cm area within the treatment area). Secondary outcomes included treatment-associated pain (numeric rating scale, NRS), Actinic Keratosis Area and Severity Index (AKASI), total lesion count over time, skin preparation, safety, overall assessment of effectiveness, tolerability, adherence and patient satisfaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 224 patients [median age 75.0 (range 50\u201391) years, 85.3% male, 62.5% AK Olsen grade 2, 55.4% treatment-na\u00efve] were included and treated with MAL-ADL-PDT. Three months after treatment, lesion counts were reduced in the focus area by 71% (P &amp;lt; 0.001) indicating practicability of the treatment. Nearly all patients (93.3%) experienced no or mild pain during PDT (NRS score 0\u20133). Median AKASI decreased from 6.2 at baseline to 3.4 at month 3 (95% confidence interval 2.4\u20133.0; P &amp;lt; 0.001). The majority of investigators (82.8%) and patients (80.0%) were satisfied with the treatment. No new safety signals were reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The clinical practicability of MAL-ADL-PDT was demonstrated under real-world conditions by effective lesion reduction and predominantly none-to-mild procedural pain. Thus, MAL-ADL-PDT is a convenient way for healthcare professionals to deliver PDT treatment to patients with AK located on the face and scalp.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljae437","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T22:16:04Z","timestamp":1731017764000},"page":"510-519","source":"Crossref","is-referenced-by-count":9,"title":["Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight"],"prefix":"10.1093","volume":"192","author":[{"given":"Wolfgang G","family":"Philipp-Dormston","sequence":"first","affiliation":[{"name":"Hautzentrum K\u00f6ln (Cologne Dermatology) , K\u00f6ln ,","place":["Germany"]},{"name":"Faculty of Health, University Witten-Herdecke , Witten ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Br\u00fcckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Ba\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Fr\u00e4nken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Gro\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Paasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Quist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice M","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf-Markus","family":"Szeimies","sequence":"additional","affiliation":[{"name":"Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2025021810040786900_ljae437-B1","first-page":"274","article-title":"Bericht zum Krebsgeschehen in Deutschland. 2016","author":"Robert-Koch-Institut","year":"2016","journal-title":"Deutsche Nationalbibliothek"},{"key":"2025021810040786900_ljae437-B2","doi-asserted-by":"publisher","DOI":"10.25646\/8353","article-title":"Krebs in Deutschland f\u00fcr 2017\/2018","author":"Robert-Koch-Institut","year":"2021","journal-title":"Deutsche Nationalbibliothek"},{"key":"2025021810040786900_ljae437-B3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09546630310012118","article-title":"A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study","volume":"14","author":"Freeman","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2025021810040786900_ljae437-B4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1365-2133.2009.09040.x","article-title":"Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies","volume":"160","author":"Hauschild","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2008.05.031","article-title":"Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study","volume":"59","author":"Pariser","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2025021810040786900_ljae437-B6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1067\/mjd.2003.49","article-title":"Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial","volume":"48","author":"Pariser","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2025021810040786900_ljae437-B7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2133.2012.10887.x","article-title":"Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy","volume":"167","author":"Szeimies","year":"2012","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00015550510032887","article-title":"A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp","volume":"85","author":"Tarstedt","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"2025021810040786900_ljae437-B9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.23736\/S0392-0488.18.06011-X","article-title":"Pain perception during photodynamic therapy: why is daylight PDT with methyl aminolevulinate almost pain-free? A review on the underlying mechanisms, clinical reflections and resulting opportunities","volume":"153","author":"Szeim\u00efes","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"2025021810040786900_ljae437-B10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1524-4725.2009.01096.x","article-title":"Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study","volume":"35","author":"Szeimies","year":"2009","journal-title":"Dermatol Surg"},{"key":"2025021810040786900_ljae437-B11","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jdv.13228","article-title":"Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe","volume":"29","author":"Lacour","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025021810040786900_ljae437-B12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"2025021810040786900_ljae437-B13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/bjd.13138","article-title":"Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial","volume":"171","author":"Rubel","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1352458513502113","article-title":"Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study","volume":"20","author":"Havrdova","year":"2014","journal-title":"Mult Scler"},{"key":"2025021810040786900_ljae437-B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2012.11200.x","article-title":"Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations","volume":"168","author":"Wiegell","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","article-title":"Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial","volume":"160","author":"Wiegell","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B17","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1080\/09546634.2021.1944594","article-title":"A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging","volume":"33","author":"Arisi","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2025021810040786900_ljae437-B18","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1111\/jdv.16112","article-title":"Artificial white light photodynamic therapy for actinic keratosis: a study of 38 patients in private office practice","volume":"34","author":"Maire","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025021810040786900_ljae437-B19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/jdv.14267","article-title":"A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index","volume":"31","author":"Dirschka","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025021810040786900_ljae437-B20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjd.14509","article-title":"Temperature-dependent impact of thermal aminolaevulinic acid photodynamic therapy on apoptosis and reactive oxygen species generation in human dermal fibroblasts","volume":"175","author":"Mamalis","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025021810040786900_ljae437-B21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jamadermatol.2015.5436","article-title":"Artificial white light vs daylight photodynamic therapy for actinic keratoses: a randomized clinical trial","volume":"152","author":"O\u2019Gorman","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2025021810040786900_ljae437-B22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0781.2011.00611.x","article-title":"Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses","volume":"27","author":"Wiegell","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025021810040786900_ljae437-B23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1684\/ejd.2018.3492","article-title":"Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI)","volume":"29","author":"Jordan","year":"2019","journal-title":"Eur J Dermatol"},{"key":"2025021810040786900_ljae437-B24","doi-asserted-by":"crossref","first-page":"104049","DOI":"10.1016\/j.pdpdt.2024.104049","article-title":"The impact of occlusive vs non-occlusive application of methyl aminolevulinate on the efficacy and tolerability of daylight photodynamic therapy for actinic keratosis","volume":"46","author":"Trave","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2025021810040786900_ljae437-B25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/jdv.14691","article-title":"Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries","volume":"32","author":"Fargnoli","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025021810040786900_ljae437-B26","doi-asserted-by":"crossref","first-page":"102618","DOI":"10.1016\/j.pdpdt.2021.102618","article-title":"Clinical evaluation of a short illumination duration (1\u2005hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source","volume":"36","author":"Creusot","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2025021810040786900_ljae437-B27","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jdv.14703","article-title":"Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression","volume":"32","author":"Philipp-Dormston","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae437\/60940090\/ljae437.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/3\/510\/60940090\/ljae437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/3\/510\/60940090\/ljae437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:04:23Z","timestamp":1739873063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/3\/510\/7885256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,7]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae437","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,11,7]]}}}